Intensity Therapeutics shareholders approve reverse stock split ratio of 1:5 to 1:30

INTENSITY THERAPEUTICS, INC.

Reverse split proposal passed with 18,333,570 For, 4,508,502 Against, 27,490 Abstain.
Adjournment proposal also approved: 18,869,741 For, 3,893,779 Against, 106,042 Abstain.
Quorum of 22,869,562 shares (46.61% of outstanding common stock) was present at the 10/22/2025 Special Meeting.
Board may set the exact ratio within 1:5 to 1:30 range or abandon the split entirely.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.